MEREDITH-SCOTT BAKER: Open Payments
NPI 1487214185 · GARNER, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$926 in 40 payments from 13 companies in 2025. Trend: 2023 $980 · 2024 $589 · 2025 $926
Food & beverage: $897Education: $29
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $202 |
| Novo Nordisk Inc | 9 | $177 |
| AstraZeneca Pharmaceuticals LP | 3 | $173 |
| ABBVIE INC. | 8 | $159 |
| Otsuka America Pharmaceutical, Inc. | 3 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $32 |
| UCB, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $16 |
Products named: OTEZLA, AIRSUPRA, VRAYLAR, Wegovy, FARXIGA, REXULTI, UBRELVY, Ozempic.
Industry payments across NC — which companies pay providers there.
